India to Taiwan: Acyclovir Export Trade Route
India has recorded 30 verified shipments of Acyclovir exported to Taiwan, representing a combined trade value of $3.0M USD. This corridor is served by 5 active Indian exporters, with an average shipment value of $101.6K USD. The leading Indian exporter is MYLAN LABORATORIES LIMITED, which accounts for 96% of total export value with 2 shipments worth $2.9M USD. On the buying side, VIATRIS PHARMACEUTICALS CO. LT,, is the largest importer in Taiwan with $2.9M USD in purchases. The top 3 suppliers — MYLAN LABORATORIES LIMITED, GMSANJIVANI LLP, GMSANJIVANI LLP — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Taiwan Acyclovir corridor is one of India's established pharmaceutical export routes, with 30 shipments documented worth a combined $3.0M USD. The route is dominated by MYLAN LABORATORIES LIMITED, which alone accounts for roughly 96% of all export value, reflecting the consolidated nature of India's acyclovir manufacturing sector.
Across 5 active suppliers, the average shipment value stands at $101.6K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with acyclovir's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 20.6%, placing it at rank #9 among India's top acyclovir export destinations globally.
On the import side, key buyers of Indian acyclovir in Taiwan include VIATRIS PHARMACEUTICALS CO. LT,,, MYLAN TAIWAN LIMITED, TO THE MANAGER- and 7 others. VIATRIS PHARMACEUTICALS CO. LT,, is the single largest importer with 1 shipments valued at $2.9M USD.
